Survival analyses of raw CD4+, CD8+, and CD45+ tumor-infiltrating immune cell percentages revealed that the higher the CD4+ (p = 0.0028) and the CD45+ (p = 0.0221) infiltration within the FFPE samples was, the longer the overall survival (OS) of the patients. This evidence concerns the gene CD4 and neoplasm.